Ingevity (NGVT) SVP Michael Shukov granted 1,389 restricted stock units

Rhea-AI Filing Summary

Ingevity Corp senior executive receives equity award. SVP and President, APT, Michael N. Shukov acquired 1,389 shares of Ingevity common stock on a grant basis, with no cash paid per share. The award is in the form of restricted stock units under the Ingevity Corporation 2025 Omnibus Incentive Plan.

The units will vest in three equal installments on February 27, 2027, February 27, 2028, and February 27, 2029, aligning the executive’s compensation with longer-term company performance through time-based vesting.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Shukov Michael N.

Role SVP and Pres, APT

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,389	$0.00	--

Holdings After Transaction: Common Stock — 1,389 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shukov Michael N.

(Last) (First) (Middle)

C/O INGEVITY CORPORATION

4920 O'HEAR AVE, SUITE 400

(Street)

NORTH CHARLESTON SC 29405

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and Pres, APT

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		1,389(1)	A	$0	1,389	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, which will vest in three equal installments on February 27, 2027, 2028, and 2029.

Remarks:

	Michael N. Shukov By: Mavis Huger as Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ingevity (NGVT) executive Michael Shukov report on this Form 4?

Michael N. Shukov reported receiving an equity award of 1,389 Ingevity common shares as a grant of restricted stock units. The award is part of his compensation and was made under the Ingevity Corporation 2025 Omnibus Incentive Plan.

How many Ingevity (NGVT) shares were granted to Michael Shukov?

Michael Shukov was granted 1,389 shares of Ingevity common stock in the form of restricted stock units. This entire amount represents an acquisition through a grant or award, rather than an open-market purchase of existing shares.

At what price were the Ingevity (NGVT) shares granted to Michael Shukov?

The 1,389 Ingevity shares were granted to Michael Shukov at a transaction price of $0.0000 per share. This indicates a compensatory equity award, not a cash purchase, consistent with typical restricted stock unit grants to senior executives.

When will Michael Shukov’s Ingevity (NGVT) restricted stock units vest?

Michael Shukov’s restricted stock units will vest in three equal installments on February 27, 2027, February 27, 2028, and February 27, 2029. This time-based vesting schedule ties the award to his continued service over multiple years.

What plan governs Michael Shukov’s Ingevity (NGVT) equity grant?

The equity grant to Michael Shukov is issued under the Ingevity Corporation 2025 Omnibus Incentive Plan. This plan authorizes grants of restricted stock units and other awards intended to align executive compensation with company performance and shareholder interests.

Is Michael Shukov’s Ingevity (NGVT) Form 4 transaction a buy or a grant?

The transaction is a grant of restricted stock units, not an open-market share purchase. It is classified as an acquisition through a grant or award, with a reported price of $0.0000 per share and time-based vesting conditions attached.